American depositary receipts of European stocks were trading 0.84% lower at 1,028.49 on the BNY Mellon Europe Select ADR Index on Monday.

In continental Europe, the gainers were led by internet advertising firm VEON (VEON) and biopharmaceutical company DBV Technologies (DBVT), which rose 2.9% and 2.1% respectively. They were followed by medical equipment company Edap (EDAP) and Deutsche Bank (DB), which were up 1.9% and 1.6%.

The decliners in continental Europe were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Zealand Pharma (ZEAL), which lost 3.1% and 2.4% respectively. They were followed by biopharmaceutical company MorphoSys (MOR) and petroleum industry company Equinor (EQNR), which were off 1.6% and 0.8%.

In the UK and Ireland, the gainers were led by Royal Bank of Scotland (RBS) and public relations group WPP (WPP), which rose 1.9% and 1.6% respectively. They were followed by educational publisher Pearson (PSO) and medical device maker Smith & Nephew (SNN), which were up 1.2% and 1.1%.

The decliners in the UK and Ireland were led by specialty pharmaceutical firm Motif Bio (MTFB) and pharmaceutical company Avadel (AVDL), which fell 11.5% and 8.2% respectively. They were followed by airline operator Ryanair (RYAAY) and Trinity Biotech (TRIB), which dropped 4.2% and 1.4%.